Detection and Reporting of Homozygosity Associated with Consanguinity in the Clinical Laboratory
Author(s) -
Kristen L. Sund,
Catherine Rehder
Publication year - 2014
Publication title -
human heredity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.423
H-Index - 62
eISSN - 1423-0062
pISSN - 0001-5652
DOI - 10.1159/000362448
Subject(s) - consanguinity , proband , runs of homozygosity , genetic testing , snp array , disease gene identification , genetics , discretion , biology , medicine , phenotype , single nucleotide polymorphism , exome sequencing , gene , mutation , genotype , political science , law
The detection of consanguinity by the presence of multiple regions of homozygosity (ROH) is not an uncommon occurrence in clinical laboratories performing SNP microarray analysis. Reporting practices amongst laboratories are highly variable, due in part to differences in testing platforms, threshold parameters, language utilized, and laboratory policies. While guidance documents have provided a framework for detection and reporting practices, and will doubtless serve to harmonize the field, there are still many facets of the testing that remain at the discretion of the performing laboratory. Clinician and patient education remain a high priority. In the clinical laboratory, these homozygous segments are often examined to identify genes associated with a phenotype that matches that of the proband and autosomal recessive inheritance. While the detection of these ROH is possible with whole genome sequencing, it currently requires special algorithms be utilized, an uncommon practice in most clinical laboratories currently performing this type of testing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom